Compare Altria Group Inc (MO) vs Pfizer Inc (PFE) Price & Performance

Altria Group IncTrade

Pfizer IncTrade

Price performance (Past 24H)

Key statistics

Altria Group Inc vs Pfizer Inc — how do they compare? Altria Group Inc trades at $73.25 (market cap $124.67B), while Pfizer Inc trades at $24.93 (market cap $141.06B). The key difference: Altria Group Inc and Pfizer Inc are close in size by market cap, and Pfizer Inc pays the higher dividend (6.95%). Which is the better fit depends on your goals.

	MO	PFE
Market Cap	$124.67B	$141.06B
Sector	Consumer Staples	Health
52-Week High	$74.66	$28.56
52-Week Low	$54.72	$23.29
Enterprise Value	$145.75B	$191.72B
Dividend Yield	5.68%	6.95%
Volume	—	29,869,932

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Altria Group Inc

No Aura AI signal available yet.

Pfizer Inc

Pfizer (PFE) trades at $25.05, down 0.36% on the day, with a bullish technical signal supported by strong quarterly earnings beats. The company maintains solid profitability with a 73.51% gross margin and 11.83% net income margin, though revenue has moderated post-pandemic. Recent news highlights pipeline advancements in oncology and obesity treatments, positioning PFE for potential growth catalysts in 2026.

The outlook for Pfizer is cautiously optimistic, with a consensus price target of $28.25 offering 13% upside. Key opportunities include dividend stability and pipeline innovation, while risks involve patent cliffs and competitive pressures. Analyst sentiment is mixed with 38% buy ratings, reflecting balanced views on recovery potential versus near-term challenges.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

Dividend Harvesting Portfolio tops $40K with 43.6% return, focusing on growing income and tech sector bets.Seeking Alpha · 1 day agoBullish SPYI ETF yields 12% but faces pressure as volatility drops and Treasury yields rise.24/7 Wall Street · 4 days agoNeutral View details →

PFE

Over 180 companies develop 200+ PD-1/PD-L1 inhibitors, reshaping cancer treatment landscape.Delveinsight · 4 hours agoBullish New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral View details →

About Altria Group Inc

Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.